Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I/II trial is studying the side effects and best dose of oxaliplatin in treating
patients with newly diagnosed glioblastoma multiforme. Drugs used in chemotherapy, such as
oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing